On the leading edge of urology

Seymour Kilstein, DO, FACOS - Guest Columnist

Before getting into the details of today’s subject, I would like to once again thank all the good people of Harlan and the entire region for treating me with so much kindness and giving me constant support. You have treated me and my wife very well and we appreciate it.

I feel at home here in Harlan. This has prompted me to sign an extension of my contract from three years to six years. I very much wish to thank Donnie Fields, the CEO at Harlan ARH Hospital, who made this possible. He has been a true friend to me, not just my boss.

On May 18, I celebrated my first anniversary practicing urology in Harlan. You have been great to me and this will remain my home.

Now, on to just a few of the new and exciting things that we can offer to our patients at Harlan ARH.

First we have some new things coming up soon. There is a new treatment for erectile dysfunction that should be approved by the FDA in the not-so-distant future.

Instead of expensive pills like Viagra, this treatment using focused shock waves has been shown to take care of the problem of increasing blood flow. This method has been approved in 20 countries already.

It has the added benefit of being an office procedure without pain, and it does not require anesthesia.

The first FDA approved drug for females to improve sexual desire and female sexual dysfunction is called Flibanserin. It can be used only in pre-menopausal women. Alcohol must not be taken while on this medicine.

Physicians who prescribe the drug and the pharmacists who dispense it must get certification to use the drug. My certification should be completed by next month.

There have been some very beneficial side effects noted recently among patients being treated for their high cholesterol levels. The use of anti-cholesterol drugs like Crestor has shown to benefit prostate cancer patients. Men who have been treated for that disease have a 30 percent less chance for recurrence when they take these cholesterol-lowering medications.

These same drugs may also help prevent the formation of kidney stones.

When I started practicing urology here I was astounded to find out that almost 100 percent of the patients in this area are not on any stone prevention program once they had stones. In fact, of the first 200 of these patients I had seen, none had ever heard of a stone prevention program.

The approach I use can reduce the chance of the patient forming another stone from 100 percent to less than five percent. Urologists around the country, myself included, have been using a method of urine collection over 24 hours. We then measure the levels of the 25 products that the kidneys produce in a day.

Any excess or deficiency in these products can be treated by very benign medications. That, along with dietary recommendations, reduces the chances of forming another stone by 95 percent.

Finally, as a Philadelphia boy and a basketball player, I just want to say that a Philadelphia team, Villanova, won the NCAA basketball tournament by hustle, great foul shooting, forcing turnovers and, maybe most importantly, by playing together for four years. Hopefully, the University of Kentucky will come to emulate that program.

Seymour Kilstein, DO, is a urologist at the ARH Daniel Boone Clinic


Seymour Kilstein, DO, FACOS

Guest Columnist

comments powered by Disqus